VCR ventracor limited


  1. 22,691 Posts.

    Ventracor ‘Artificial Heart’ Pilot Trial Update Sydney, 1 September 2003:
    Medical investigators today announced the second implant of Australia’s ‘artificial heart’ at The Alfred hospital in Melbourne.

    Chief Medical Investigators, Professor Don Esmore and Professor David Kaye, said the patient was in a serious but stable condition.

    The second implant of Ventracor’s VentrAssist ™ Left Ventricular Assist System (LVAS) is part of a Pilot Trial at The Alfred hospital to evaluate the safety of the device in 10 patients.

    At the discretion of the medical investigators, further patients are expected to be enrolled in due course. In line with Ventracor’s stated policy of timely market updates, further information on the progress of the patient will be made at appropriate times in the future.

    The trial results will be based on outcomes from all 10 patients. While individual outcomes are very important, it is the accumulation of all data on the safety of the device that will decide the outcome of the trial.

    Patients who are eligible to be implanted with the VentrAssist™ system are gravely ill. They are not eligible for heart transplantation and are no longer responding to optimal medical therapy.

    For more information, please contact: Michael Spooner Trisha Lee Ventracor Limited The Alfred Managing Director & CEO Public Affairs Manager 02 9406 3088 03 9276 2266 Ventracor Limited 126 Greville Street Chatswood NSW 2067 Australia
    T +61 2 9406 3100 F +61 2 9406 3101 W
    ABN 46 003 180 372
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.